Giles Creative Artworker

ABOUT

Promotional material and congress assets for multiple sclerosis (MS) drug Mavenclad (cladribine).

MADEIT CREDITS

  • MerckClient
studiopro:Giles was verified as a studiopro on 26th October 2023

Mavenclad (cladribine) Promotion

*
*
*
*

Comments